Clinical application of oral Chinese Patent Medicines in ophthalmology: a scoping review protocol

Introduction The prevalence of eye diseases has been increasing worldwide. In China, in addition to conventional medicine, Traditional Chinese Medicine (TCM) plays an important role in maintaining people’s vision health. Although less flexible and targeted than TCM decoction, Chinese Patent Medicine...

Full description

Saved in:
Bibliographic Details
Main Authors: Wei Zhou, Kai Xu, Ziyang Huang, Xiaoyu Li, Xing Liao, Lina Liang, Yamin Li, Qianqian Zuo
Format: Article
Language:English
Published: BMJ Publishing Group 2022-06-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/12/6/e059571.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832584298578837504
author Wei Zhou
Kai Xu
Ziyang Huang
Xiaoyu Li
Xing Liao
Lina Liang
Yamin Li
Qianqian Zuo
author_facet Wei Zhou
Kai Xu
Ziyang Huang
Xiaoyu Li
Xing Liao
Lina Liang
Yamin Li
Qianqian Zuo
author_sort Wei Zhou
collection DOAJ
description Introduction The prevalence of eye diseases has been increasing worldwide. In China, in addition to conventional medicine, Traditional Chinese Medicine (TCM) plays an important role in maintaining people’s vision health. Although less flexible and targeted than TCM decoction, Chinese Patent Medicines (CPMs) are stable and well used. In recent years, CPMs have been increasingly used in ophthalmology clinics by TCM practitioners and by Western doctors in general hospitals. However, comprehensive evidence for using CPMs in ophthalmology is lacking.Aim We will apply the methodology of scoping review to systematically search and sort out the available evidence on oral CPMs for the treatment of eye diseases, identify the distribution of evidence in this field and provide a basis for clinical practice and medical decisions.Methods The scoping review will be implemented in the following seven steps: (1) defining the research question; (2) searching National Essential Medicines List (2018 edition), National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2020 edition) and Chinese Pharmacopoeia (2020 edition) for oral CPMs for the treatment of eye diseases; (3) searching Embase, Web of Science, PubMed, Cochrane Library, Chongqing VIP Chinese Scientific Journals Database, Chinese National Knowledge Infrastructure, Chinese Biomedical Literature Database and Wanfang Database for relevant literature published from inception to December 2021; (4) developing eligibility criteria; (5) screening the studies based on inclusion criteria; (6) extracting relevant data and lastly, (7) collating, summarising and reporting the results.Ethics and dissemination Since the scoping review aims at collecting data from publicly available publications, this study does not require ethical approval. The results will be published in a peer-reviewed journal and presented at scientific conferences.
format Article
id doaj-art-1b2540e5eda54703a79ee2b10cd34703
institution Kabale University
issn 2044-6055
language English
publishDate 2022-06-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj-art-1b2540e5eda54703a79ee2b10cd347032025-01-27T14:25:14ZengBMJ Publishing GroupBMJ Open2044-60552022-06-0112610.1136/bmjopen-2021-059571Clinical application of oral Chinese Patent Medicines in ophthalmology: a scoping review protocolWei Zhou0Kai Xu1Ziyang Huang2Xiaoyu Li3Xing Liao4Lina Liang5Yamin Li6Qianqian Zuo7Department of Emergency, Shanghai Jiao Tong University School of Medicine Affiliated Renji Hospital, Shanghai, China2 Department of Anesthesiology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, ChinaEye Hospital, China Academy of Chinese Medical Sciences, Beijing, ChinaEye Hospital, China Academy of Chinese Medical Sciences, Beijing, ChinaInstitute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, ChinaGuangzhou Institute of Respiratory Disease, Guangzhou, Guangdong, ChinaClinical Nursing Teaching and Research Section, The Second Xiangya Hospital of Central South University, Changsha, ChinaEye Hospital, China Academy of Chinese Medical Sciences, Beijing, ChinaIntroduction The prevalence of eye diseases has been increasing worldwide. In China, in addition to conventional medicine, Traditional Chinese Medicine (TCM) plays an important role in maintaining people’s vision health. Although less flexible and targeted than TCM decoction, Chinese Patent Medicines (CPMs) are stable and well used. In recent years, CPMs have been increasingly used in ophthalmology clinics by TCM practitioners and by Western doctors in general hospitals. However, comprehensive evidence for using CPMs in ophthalmology is lacking.Aim We will apply the methodology of scoping review to systematically search and sort out the available evidence on oral CPMs for the treatment of eye diseases, identify the distribution of evidence in this field and provide a basis for clinical practice and medical decisions.Methods The scoping review will be implemented in the following seven steps: (1) defining the research question; (2) searching National Essential Medicines List (2018 edition), National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2020 edition) and Chinese Pharmacopoeia (2020 edition) for oral CPMs for the treatment of eye diseases; (3) searching Embase, Web of Science, PubMed, Cochrane Library, Chongqing VIP Chinese Scientific Journals Database, Chinese National Knowledge Infrastructure, Chinese Biomedical Literature Database and Wanfang Database for relevant literature published from inception to December 2021; (4) developing eligibility criteria; (5) screening the studies based on inclusion criteria; (6) extracting relevant data and lastly, (7) collating, summarising and reporting the results.Ethics and dissemination Since the scoping review aims at collecting data from publicly available publications, this study does not require ethical approval. The results will be published in a peer-reviewed journal and presented at scientific conferences.https://bmjopen.bmj.com/content/12/6/e059571.full
spellingShingle Wei Zhou
Kai Xu
Ziyang Huang
Xiaoyu Li
Xing Liao
Lina Liang
Yamin Li
Qianqian Zuo
Clinical application of oral Chinese Patent Medicines in ophthalmology: a scoping review protocol
BMJ Open
title Clinical application of oral Chinese Patent Medicines in ophthalmology: a scoping review protocol
title_full Clinical application of oral Chinese Patent Medicines in ophthalmology: a scoping review protocol
title_fullStr Clinical application of oral Chinese Patent Medicines in ophthalmology: a scoping review protocol
title_full_unstemmed Clinical application of oral Chinese Patent Medicines in ophthalmology: a scoping review protocol
title_short Clinical application of oral Chinese Patent Medicines in ophthalmology: a scoping review protocol
title_sort clinical application of oral chinese patent medicines in ophthalmology a scoping review protocol
url https://bmjopen.bmj.com/content/12/6/e059571.full
work_keys_str_mv AT weizhou clinicalapplicationoforalchinesepatentmedicinesinophthalmologyascopingreviewprotocol
AT kaixu clinicalapplicationoforalchinesepatentmedicinesinophthalmologyascopingreviewprotocol
AT ziyanghuang clinicalapplicationoforalchinesepatentmedicinesinophthalmologyascopingreviewprotocol
AT xiaoyuli clinicalapplicationoforalchinesepatentmedicinesinophthalmologyascopingreviewprotocol
AT xingliao clinicalapplicationoforalchinesepatentmedicinesinophthalmologyascopingreviewprotocol
AT linaliang clinicalapplicationoforalchinesepatentmedicinesinophthalmologyascopingreviewprotocol
AT yaminli clinicalapplicationoforalchinesepatentmedicinesinophthalmologyascopingreviewprotocol
AT qianqianzuo clinicalapplicationoforalchinesepatentmedicinesinophthalmologyascopingreviewprotocol